E-LIB Suche - Ergebnisse für: Ong, Pei Shi

1

Contributors:

, In: Microfluidic Devices for Biomedical Applications,

Abdallah, B.G. ; Ali, M.M. ; Benhabib, Merwan... - p. xi-xiv , 2021

Link: https://doi.org/10.1016/..

2

Microfluidic systems for drug discovery, pharmaceutical ana..:

, In: Microfluidic Devices for Biomedical Applications,

Ding, Dawei ; Park, Sol ; Kochhar, Jaspreet Singh... - p. 261-327 , 2021

Link: https://doi.org/10.1016/..

3

Celastrol in cancer therapy: Recent developments, challenge..:

Lim, Hannah Ying ; Ong, Pei Shi ; Wang, Lingzhi...
Cancer Letters. 521 (2021) - p. 252-267 , 2021

Link: https://doi.org/10.1016/..

4

Resveratrol for cancer therapy: Challenges and future persp..:

Ren, Boxu ; Kwah, Marabeth Xin-Yi ; Liu, Cuiliu...
Cancer Letters. 515 (2021) - p. 63-72 , 2021

Link: https://doi.org/10.1016/..

5

Strategies for Incorporating Pharmacokinetic Studies into O..:

, In: Phase I Oncology Drug Development,

Wang, Lingzhi ; Chong, Wan Qin ; Ong, Pei Shi. - p. 119-138 , 2020

Link: https://doi.org/10.1007/..

6

Pan-HDAC inhibition by panobinostat mediates chemosensitiza..:

Wang, Lingzhi ; Syn, Nicholas Li-Xun ; Subhash, Vinod Vijay...
Cancer Letters. 417 (2018) - p. 152-160 , 2018

Link: https://doi.org/10.1016/..

7

Characterization of Steroid Refractory Graft-Versus-Host Di..:

Chong, Mui Fong ; Ong, Pei Shi ; Ho, Ying Shi..
Biology of Blood and Marrow Transplantation. 24 (2018) 3 - p. S207 , 2018

Link: https://doi.org/10.1016/..

8

Access and adherence to medications for the primary and sec..:

Koh, Joel Jun Kai ; Cheng, Rui Xiang ; Yap, Yicheng...
Patient Preference and Adherence. 12 (2018) - p. 2481-2498 , 2018

Link: https://doi.org/10.2147/..

9

A Review on Liquid Chromatography-Tandem Mass Spectrometry ..:

Wong, Andrea Li-Ann ; Xiang, Xiaoqiang ; Ong, Pei Shi...
Pharmaceutics. 10 (2018) 4 - p. 221 , 2018

Link: https://doi.org/10.3390/..

10

Quantification of desoxyrhapontigenin (4-methoxyresveratrol..:

Dai, Yu ; Tan, Amanda Li Cheng ; Chen, Huan...
Journal of Pharmaceutical and Biomedical Analysis. 153 (2018) - p. 95-101 , 2018

Link: https://doi.org/10.1016/..

11

Perception of oncology practitioners towards off-label use ..:

Saiyed, Mohd Masnoon ; Ong, Pei Shi ; Chew, Lita
Journal of Pharmaceutical Health Services Research. 8 (2017) 2 - p. 91-99 , 2017

Link: https://doi.org/10.1111/..

12

P-181 Association of DHCR7/NADSYN1-rs12785878 and GC-rs7041..:

Ong, Wan Chee ; Wan, Choon Nam ; Valerie Ng, Yun Ting...
Inflammatory Bowel Diseases. 22 (2016) - p. S64 , 2016

Link: https://doi.org/10.1097/..

13

Judicious Toggling of mTOR Activity to Combat Insulin Resis..:

Ong, Pei Shi ; Wang, Louis Z. ; Dai, Xiaoyun...
Frontiers in Pharmacology. 7 (2016) - p. , 2016

Link: https://doi.org/10.3389/..

14

P-084 Vitamin D Deficiency in Asian IBD Patients: Prevalenc..:

Ong, Wan Chee ; Wan, Choon Nam ; Ho, Choon Siang...
Inflammatory Bowel Diseases. 22 (2016) - p. S35-S36 , 2016

Link: https://doi.org/10.1097/..

15

Synergistic disruption of ERα/HER2 crosstalk by endoxifen a..:

Chan, James Chun Yip ; Ong, Pei Shi ; Lim, Peirong..
Cancer Chemotherapy and Pharmacology. 79 (2016) 1 - p. 117-130 , 2016

Link: https://doi.org/10.1007/..